You have 9 free searches left this month | for more free features.

bendamustine

Showing 51 - 75 of 173

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Bendamustine
  • +8 more
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Lymphoma Trial in Worldwide (Bendamustine, Obinutuzumab, Polatuzumab vedotin (Liquid))

Completed
  • Lymphoma
  • Bendamustine
  • +4 more
  • Birmingham, Alabama
  • +61 more
Oct 18, 2022

Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Duarte, California
  • +4 more
Jun 27, 2022

Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Bendamustine, Obinutuzumab, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Bendamustine
  • +3 more
  • La Jolla, California
  • +11 more
Oct 12, 2020

Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Trial in United States (CD30.CAR-T, Fludarabine,

Active, not recruiting
  • Hodgkin Lymphoma, Adult
  • +3 more
  • Duarte, California
  • +4 more
Apr 3, 2022

DLBCL, Lymphoma Follicular Trial in Australia, Italy, United States (Atezolizumab, Bendamustine, Cyclophosphamide)

Completed
  • Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
  • Aurora, Colorado
  • +20 more
Apr 26, 2021

Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in New York, Vancouver, Toronto (Brentuximab Vedotin, Bendamustine,

Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • New York, New York
  • +2 more
Jul 15, 2020

Classical Hodgkin Lymphoma Trial in Belgium, France (Bendamustine, Prednisone, Vinblastine)

Completed
  • Classical Hodgkin Lymphoma
  • Bendamustine
  • +3 more
  • Bruges, Belgium
  • +39 more
Feb 18, 2021

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Bendamustine
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

Recruiting
  • Mantle Cell Lymphoma
  • +5 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Aberdeen, United Kingdom
  • +24 more
Apr 28, 2023

Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)

Suspended
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Tucson, Arizona
  • +17 more
Jan 24, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Chronic Lymphocytic Leukemia Trial in Cologne (Bendamustine, Ofatumumab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Bendamustine
  • +2 more
  • Cologne, Germany
    German CLL Study Group
Jun 9, 2020

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Bendamustine
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

AL Amyloidosis Trial in Boston, Detroit, New York (Bendamustine, Dexamethasone)

Completed
  • AL Amyloidosis
  • Boston, Massachusetts
  • +5 more
Mar 17, 2020

DLBCL, DLBCL Trial in Worldwide (Zilovertamab vedotin, Rituximab, Gemcitabine)

Recruiting
  • DLBCL
  • Diffuse Large B-Cell Lymphoma
  • Zilovertamab vedotin
  • +4 more
  • Whittier, California
  • +21 more
Nov 30, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Mantle Cell Lymphoma Trial in Seoul (Bendamustine)

Unknown status
  • Mantle Cell Lymphoma
  • Bendamustine
  • Seoul, Korea, Republic of
  • +1 more
Mar 16, 2020

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Downey, California
  • +231 more
Jan 16, 2023

Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)

Active, not recruiting
  • Advanced Follicular Lymphoma
  • Boulder, Colorado
  • +33 more
Nov 21, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Bendamustine
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023